A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder (Q80072870)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

Mark H Pollack

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Ulla Lepola

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Hannu Koponen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Naomi M Simon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

John J Worthington

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Gerard Emilien

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Evan Tzanis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Eliseo Salinas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Timothy Whitaker

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Bo Gao

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

published in

Depression and Anxiety

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

ECT, research, and professional ambivalence

28 December 2019

cites work

1 reference

7 January 2021

Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study

1 reference

7 January 2021

Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine

1 reference

7 January 2021

How psychiatrists can build new therapies for impotence

1 reference

7 January 2021

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder

1 reference

7 January 2021

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

1 reference

7 January 2021

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial

1 reference

7 January 2021

A Comparison of Fluvoxamine, Cognitive Therapy, and Placebo in the Treatment of Panic Disorder

1 reference

7 January 2021

Social adjustment in generalised anxiety disorder: a long-term placebo-controlled study of venlafaxine extended release

1 reference

7 January 2021

Major depression in patients with agoraphobia and panic disorder

1 reference

7 January 2021

Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness

1 reference

7 January 2021

Quality of life in patients with panic disorder.

1 reference

7 January 2021

Naltrexone-induced reduction of tobacco intake

1 reference

7 January 2021

Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.

1 reference

7 January 2021

The assessment of anxiety states by rating

1 reference

7 January 2021

A rating scale for depression

1 reference

7 January 2021

Dose-response relationship with venlafaxine

1 reference

7 January 2021

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

1 reference

7 January 2021

The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group

1 reference

7 January 2021

Panic attacks in the community. Social morbidity and health care utilization

1 reference

7 January 2021

A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators

1 reference

7 January 2021

Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators

1 reference

7 January 2021

Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder

1 reference

7 January 2021

A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder.

1 reference

7 January 2021

Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation

1 reference

7 January 2021

Quality of life in panic disorder.

1 reference

7 January 2021

Brief standard self-rating for phobic patients

1 reference

7 January 2021

Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trial

1 reference

7 January 2021

Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group

1 reference

7 January 2021

Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group

1 reference

7 January 2021

Effectiveness of venlafaxine, extended release formulation, in the short-term and long-term treatment of generalized anxiety disorder: results of a survival analysis

1 reference

7 January 2021

Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR.

1 reference

7 January 2021

Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study

1 reference

7 January 2021

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

1 reference

7 January 2021

WCA recommendations for the long-term treatment of panic disorder.

1 reference

7 January 2021

Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.

1 reference

7 January 2021

Sertraline treatment of panic disorder: results of a long-term study

1 reference

7 January 2021

A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder

1 reference

7 January 2021

Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.

1 reference

7 January 2021

Paroxetine response and tolerability among ethnic minority patients with mood or anxiety disorders: a pooled analysis.

1 reference

7 January 2021

A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression

1 reference

7 January 2021

Multicenter collaborative panic disorder severity scale

1 reference

7 January 2021

The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies

1 reference

7 January 2021

Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder

1 reference

7 January 2021

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis

1 reference

7 January 2021

Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.

1 reference

7 January 2021

Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial

1 reference

7 January 2021

Major depression in patients with panic disorder: factors associated with course and recurrence

1 reference

7 January 2021

Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder

1 reference

7 January 2021

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

1 reference

7 January 2021

Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.

1 reference

7 January 2021

The effect of citalopram in panic disorder

1 reference

7 January 2021

Predicting prospective episodes of depression in patients with panic disorder: a longitudinal study

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.20218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894619%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference